I joined the NUKEMS Committee as Secretary in 2017 during my studies for my PhD on an exposure model in in vitro genotoxicity testing at Swansea University (supervised by past UKEMS President, Prof. Gareth Jenkins). Following my PhD, I worked on in vitro toxicology in drug development at Cardiff University before joining Imperial Brands as a Pre-Clinical Toxicologist in 2019. Since then, I have moved to focus on regulatory science, first as a Senior Regulatory Science Writer and now a Regulatory Scientific Strategy Manager. I became Chair of NUKEMS in April 2020, and rotated from this position in July 2023 into a Past Chair role, alongside joining the UKEMS Committee as an Ordinary Member. I have been a member of UKEMS since 2015 and am very grateful for the amazing support they offer to New Investigators, from opportunities to present their work, to a great selection of funding opportunities. I’m proud of the achievements of the NUKEMS Committee in supporting and enthusing early career scientists to date and to be a part of this.